載入...
Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6 blockade–refractory idiopathic multicentric Castleman disease
BACKGROUND: Idiopathic multicentric Castleman disease (iMCD) is a hematologic illness involving cytokine-induced lymphoproliferation, systemic inflammation, cytopenias, and life-threatening multi-organ dysfunction. The molecular underpinnings of interleukin-6 (IL-6) blockade–refractory patients rema...
Na minha lista:
| 發表在: | J Clin Invest |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Clinical Investigation
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6763254/ https://ncbi.nlm.nih.gov/pubmed/31408438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI126091 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|